Yuviwel (Navepegritide): Once-Weekly Shot to Help With Growth in Children With Achondroplasia

Yuviwel (navepegritide) is a once-weekly shot for children 2 and older with achondroplasia who still have open growth plates. It is approved by the FDA to help increase height in this group. Yuviwel is a… Read more

Wakix: FDA Expands Approval to Treat Sudden Muscle Weakness in Children With Narcolepsy

Wakix (pitolisant) is a prescription medication used to treat narcolepsy, a long-term neurological sleep disorder that causes excessive daytime sleepiness and, in many cases, cataplexy (sudden muscle weakness triggered by strong emotions). The FDA has… Read more

FDA Approves Darzalex Faspro as Part of a New First-Line Quadruplet Regimen for Multiple Myeloma

Darzalex Faspro is an injectable medicine used to treat adults with multiple myeloma, a type of blood cancer, and light chain (AL) amyloidosis, a rare condition caused by the buildup of abnormal proteins in organs.… Read more

FDA Approves Yartemlea, the First and Only Treatment for Transplant-Related Blood Vessel Damage

Yartemlea (narsoplimab-wuug) is a new medicine approved by the FDA for treating a rare and serious condition called transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children ages 2 years or older. TA-TMA is a serious… Read more

Vybrique Gets FDA Nod as a First Oral Film for Treating Erectile Dysfunction

Vybrique (sildenafil) is a new form of treatment for erectile dysfunction (ED) in adult men. It’s the first version of sildenafil available in the U.S. as a single-dose oral film that dissolves on your tongue… Read more

Aqvesme: FDA Approves First Pill for Treating Anemia in Adults With Alpha- or Beta- Thalassemia

Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and those who don’t require regular blood transfusions. Thalassemia is a… Read more

Nereus: FDA Approves New Pill to Help With Motion Sickness

Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such as during car rides, boat trips, or flights. Motion sickness… Read more

Keytruda With Paclitaxel: FDA Approves New Combination Therapy for Certain Cancers Affecting the Ovaries, Fallopian Tubes, or Peritoneum

The FDA has approved a new combination therapy for adults with epithelial cancers that start in the ovaries, fallopian tubes, or lining of the abdomen (peritoneum). This treatment is meant for patients whose cancers express… Read more

Hernexeos: FDA Approves First-Line Use for Certain Advanced Non-Small-Cell Lung Cancers With HER2 Mutations

Hernexeos (zongertinib) is a prescription medicine known as a kinase inhibitor that is used for treating adults with advanced non-small-cell lung cancer (NSCLC) that cannot be removed surgically or has spread to other parts of… Read more

Adquey: FDA Approves New Nonsteroidal Ointment for Mild to Moderate Eczema

Adquey (difamilast 1%) is a prescription ointment the FDA has approved for adults and for children 2 and older who have mild to moderate atopic dermatitis (AD), often called eczema. It is a nonsteroidal medicine… Read more